Notices. Notice of meeting

7,196 words·~33 min read·/register/2008/02/01/08-435

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

BILLING CODE 6560-50-P ENVIRONMENTAL PROTECTION AGENCY [EPA-HQ-ORD-2007-1148; FRL-8524-2] Board of Scientific Counselors, Computational Toxicology Subcommittee Meeting—February 2008 AGENCY: Environmental Protection Agency (EPA). ACTION: Notice of meeting. SUMMARY: Pursuant to the Federal Advisory Committee Act, Public Law 92-463, the Environmental Protection Agency, Office of Research and Development (ORD), gives notice of one meeting of the Board of Scientific Counselors

(BOSC)Computational Toxicology Subcommittee. DATES: The meeting (via conference call) will be held on Wednesday, February 20, 2008 from 10 a.m. to 12 noon eastern time. The meeting may adjourn early if all business is finished. Requests for the draft agenda or for making oral presentations at the meeting will be accepted up to 1 business day before the meeting. ADDRESSES: Participation in the conference call will be by teleconference only—a meeting room will not be used. Members of the public may obtain the call-in number and access code for the call from Lorelei Kowalski, whose contact information is listed under the FOR FURTHER INFORMATION CONTACT section of this notice. Submit your comments, identified by Docket ID No. EPA-HQ-ORD-2007-1148, by one of the following methods: • *http://www.regulations.gov:* Follow the on-line instructions for submitting comments. • *E-mail:* Send comments by electronic mail (e-mail) to: *ORD.Docket@epa.gov,* Attention Docket ID No. EPA-HQ-ORD-2007-1148. • *Fax:* Fax comments to:

(202)566-0224, Attention Docket ID No. EPA-HQ-ORD-2007-1148. • *Mail:* Send comments by mail to: Board of Scientific Counselors, Computational Toxicology Subcommittee Meetings—end 2007/early 2008 Docket, Mailcode: 28221T, 1200 Pennsylvania Ave., NW., Washington, DC 20460, Attention Docket ID No. EPA-HQ-ORD-2007-1148. • *Hand Delivery or Courier.* Deliver comments to: EPA Docket Center (EPA/DC), Room B102, EPA West Building, 1301 Constitution Avenue, NW., Washington, DC, Attention Docket ID No. EPA-HQ-ORD-2007-1148. Note: This is not a mailing address. Such deliveries are only accepted during the docket's normal hours of operation, and special arrangements should be made for deliveries of boxed information. *Instructions:* Direct your comments to Docket ID No. EPA-HQ-ORD-2007-1148. EPA's policy is that all comments received will be included in the public docket without change and may be made available online at *http://www.regulations.gov,* including any personal information provided, unless the comment includes information claimed to be Confidential Business Information

(CBI)or other information whose disclosure is restricted by statute. Do not submit information that you consider to be CBI or otherwise protected through *http://www.regulations.gov* or e-mail. The *http://www.regulations.gov* Web site is an “anonymous access” system, which means EPA will not know your identity or contact information unless you provide it in the body of your comment. If you send an e-mail comment directly to EPA without going through *http://www.regulations.gov,* your e-mail address will be automatically captured and included as part of the comment that is placed in the public docket and made available on the Internet. If you submit an electronic comment, EPA recommends that you include your name and other contact information in the body of your comment and with any disk or CD-ROM you submit. If EPA cannot read your comment due to technical difficulties and cannot contact you for clarification, EPA may not be able to consider your comment. Electronic files should avoid the use of special characters, any form of encryption, and be free of any defects or viruses. For additional information about EPA's public docket visit the EPA Docket Center homepage at *http://www.epa.gov/epahome/dockets.htm.* *Docket:* All documents in the docket are listed in the *http://www.regulations.gov* index. Although listed in the index, some information is not publicly available, e.g., CBI or other information whose disclosure is restricted by statute. Certain other material, such as copyrighted material, will be publicly available only in hard copy. Publicly available docket materials are available either electronically in *http://www.regulations.gov* or in hard copy at the Board of Scientific Counselors, Computational Toxicology Subcommittee Meetings—end 2007/early 2008 Docket, EPA/DC, EPA West, Room B102, 1301 Constitution Ave., NW., Washington, DC. The Public Reading Room is open from 8:30 a.m. to 4:30 p.m., Monday through Friday, excluding legal holidays. The telephone number for the Public Reading Room is

(202)566-1744, and the telephone number for the ORD Docket is

(202)566-1752. FOR FURTHER INFORMATION CONTACT: The Designated Federal Officer via mail at: Lorelei Kowalski, Mail Code 8104-R, Office of Science Policy, Office of Research and Development, Environmental Protection Agency, 1200 Pennsylvania Avenue, NW., Washington, DC 20460; via phone/voice mail at:

(202)564-3408; via fax at:

(202)565-2911; or via e-mail at: *kowalski.lorelei@epa.gov.* SUPPLEMENTARY INFORMATION: General Information Any member of the public interested in receiving a draft BOSC agenda or making a presentation at the meeting may contact Lorelei Kowalski, the Designated Federal Officer, via any of the contact methods listed in the FOR FURTHER INFORMATION CONTACT section above. In general, each individual making an oral presentation will be limited to a total of three minutes. Proposed agenda item for the meeting includes, but is not limited to: Discussion of the subcommittee's draft report on ORD's National Center for Computational Toxicology (NCCT). The meeting is open to the public. The subcommittee roster and charge can be accessed at: *http://www.epa.gov/osp/bosc/subcomm-ctox.htm.* *Information on Services for Individuals with Disabilities:* For information on access or services for individuals with disabilities, please contact Lorelei Kowalski at

(202)564-3408 or *kowalski.lorelei@epa.gov.* To request accommodation of a disability, please contact Lorelei Kowalski, preferably at least 10 days prior to the meeting, to give EPA as much time as possible to process your request. Dated: January 28, 2008. Jeff Morris, Acting Director, Office of Science Policy. [FR Doc. E8-1852 Filed 1-31-08; 8:45 am] BILLING CODE 6560-50-P ENVIRONMENTAL PROTECTION AGENCY [FRL-8524-1] EPA Science Advisory Board; Notification of a Public Teleconference and Meeting of the Science Advisory Board Acrylamide Review Panel AGENCY: Environmental Protection Agency. ACTION: Notice. SUMMARY: The Environmental Protection Agency

(EPA)Science Advisory Board

(SAB)Staff Office announces a public teleconference and meeting of the Acrylamide Review Panel

(ARP)to review the Agency's draft assessment, “IRIS Toxicological Review of Acrylamide”. DATES: The SAB will hold the public teleconference on February 20, 2008. The teleconference will be held from 1:30 p.m. to 3:30 p.m. (Eastern Time). A face-to-face meeting will be held on March 10, 2008 and March 11, 2008 from 9 a.m. to 5 p.m. (Eastern Time) and will continue on March 12, 2008 from 9 a.m. to 1 p.m. (Eastern Time). *Location:* The February 20, 2008 telephone conference will be conducted by phone only. The March 10-12, 2008 face-to-face meeting will be held in the Washington DC metropolitan area. The actual venue will be announced on the SAB Web site at: *http://www.epa.gov/sab* . FOR FURTHER INFORMATION CONTACT: Any member of the public wishing to obtain general information concerning this public teleconference or meeting should contact Dr. Sue Shallal, Designated Federal Officer (DFO), EPA Science Advisory Board (1400F), U.S. Environmental Protection Agency, 1200 Pennsylvania Avenue, NW, Washington, DC 20460; via telephone/voice mail:

(202)343-9977; fax:

(202)233-0643; or e-mail at: *shallal.suhair@epa.gov* . General information concerning the EPA Science Advisory Board can be found on the SAB Web site at: *http://www.epa.gov./sab* . SUPPLEMENTARY INFORMATION: The SAB was established by 42 U.S.C. 4365 to provide independent scientific and technical advice to the Administrator on the technical basis for Agency positions and regulations. The SAB is a Federal Advisory Committee chartered under the Federal Advisory Committee Act (FACA), as amended, 5 U.S.C., App. The SAB will comply with the provisions of FACA and all appropriate SAB Staff Office procedural policies. Pursuant to the Federal Advisory Committee Act, Public Law 92-463, notice is hereby given that the EPA SAB Acrylamide Review Panel will hold a public teleconference and face-to-face meeting to review EPA's draft IRIS assessment. *Background:* EPA's Office of Research and Development

(ORD)had requested that the SAB peer review the Agency's draft assessment, “Toxicological Review of Acrylamide.” Background on this SAB review and the process for formation of this review panel was provided in a **Federal Register** Notice published on March 29, 2007 (72 FR 60 14804-14805). The purpose of this upcoming teleconference is for the SAB Review Panel to discuss EPA's charge questions and plan for the face-to-face meeting. The Panel will then discuss and deliberate on the charge questions at the face-to-face meeting. *Availability of Materials:* The draft agendas and other materials will be posted on the SAB Web site at: *http://www.epa.gov/sab* prior to each meeting. For questions and information concerning the Agency's draft assessment, ( *http://cfpub.epa.gov/ncea/cfm/recordisplay.cfm?deid=187729* ), please contact Dr. Rob Dewoskin, at

(919)541-1089, or *dewoskin.rob@epa.gov* . *Procedures for Providing Public Input:* Interested members of the public may submit relevant written or oral information for the Acrylamide Review Panel to consider throughout the advisory process. *Oral Statements:* In general, individuals or groups requesting an oral presentation at a public SAB teleconference will be limited to three minutes per speaker, with no more than a total of one-half hour for all speakers. At the face-to-face meeting, presentations will be limited to five minutes, with no more than a total of one hour for all speakers. To be placed on the public speaker list, interested parties should contact Dr. Sue Shallal, DFO, in writing (preferably via e-mail), by February 13, 2008 for the teleconference and by March 3, 2008 for the face-to-face meeting, at the contact information noted above. *Written Statements:* Written statements should be received in the SAB Staff Office by February 13, 2008, so that the information may be made available to the SAB for their consideration prior to the teleconference or by March 3, 2008 for their consideration prior to the face-to-face meeting. Written statements should be supplied to the DFO via e-mail to *shallal.suhair@epa.gov* (acceptable file format: Adobe Acrobat PDF, WordPerfect, MS Word, MS PowerPoint, or Rich Text files in IBM-PC/Windows 98/2000/XP format). *Accessibility:* For information on access or services for individuals with disabilities, please contact Dr. Sue Shallal at

(202)343-9977 or *shallal.suhair@epa.gov* . To request accommodation of a disability, please contact Dr. Shallal preferably at least ten days prior to the meeting, to give EPA as much time as possible to process your request. Dated January 28, 2008. Anthony F. Maciorowski, Deputy Director, EPA Science Advisory Board Staff Office. [FR Doc. E8-1869 Filed 1-31-08; 8:45 am] BILLING CODE 6560-50-P ENVIRONMENTAL PROTECTION AGENCY [FRL-8523-9] Notification of a Public Teleconference of the Science Advisory Board Exposure and Human Health Committee AGENCY: Environmental Protection Agency (EPA). ACTION: Notice. SUMMARY: The EPA Science Advisory Board

(SAB)Staff Office announces a public teleconference of the SAB Exposure and Human Health Committee

(EHHC)to discuss advisory activities for the coming year. DATES: The SAB will hold a public teleconference on February 29, 2008. The teleconference will be held from 2 p.m. to 4 p.m. (Eastern Time). ADDRESSES: The teleconference will be conducted by telephone only. FOR FURTHER INFORMATION CONTACT: Any member of the public wishing to obtain general information concerning this public teleconference or meeting should contact Dr. Sue Shallal, Designated Federal Officer (DFO), EPA Science Advisory Board (1400F), U.S. Environmental Protection Agency, 1200 Pennsylvania Avenue, NW., Washington, DC 20460; via telephone/voice mail:

(202)343-9977; fax:

(202)233-0643; or e-mail at: *shallal.suhair@epa.gov* . General information concerning the EPA Science Advisory Board can be found on the EPA SAB Web site at: *http://www.epa.gov/sab* . SUPPLEMENTARY INFORMATION: The SAB was established by 42 U.S.C. 4365 to provide independent scientific and technical advice to the Administrator on the technical basis for Agency positions and regulations. The SAB is a Federal Advisory Committee chartered under the Federal Advisory Committee Act (FACA), as amended, 5 U.S.C., App. The SAB will comply with the provisions of FACA and all appropriate SAB Staff Office procedural policies. *Background:* EPA's Office of the Science Advisor

(OSA)has requested that the SAB EHHC evaluate three Agency activities in the coming year. EPA will provide introductory briefings to the committee on:

(1)Exposure Assessment Guidelines;

(2)Immunosuppression Guidance; and

(3)Microbial Risk Assessment Guidance Document. The Agency will offer these briefings to acquaint the EHHC with the Agency's activities in preparation for future meetings. Preliminary background information on these activities follows. *Exposure Assessment Guidelines:* The practice of exposure assessment has been evolving rapidly and has changed significantly since the 1992 publication of EPA's Guidelines for Exposure Assessment. The science has advanced in the areas of personal monitoring and modeling, activity pattern analysis, and susceptible populations and life stages. The EPA has published specific guidance in such areas as probabilistic analyses, exposure factors, aggregate exposure and cumulative risk, and community-based research. The update incorporates and refers to advances and changes in the theory and practice of exposure assessment. The SAB provided a consultation on the general goals, topic areas, and approach for the update in September 2006 (SAB letter dated February 28, 2007, EPA-SAB-07-003). The SAB is asked to provide peer review, and to comment specifically on the scope and content of the updated Guidelines, the completeness and clarity of the text, the suitability of figures and tables, and the inclusion of appropriate emerging areas in this field. *Immunosuppression Guidance:* The Agency is developing a guidance document for interpreting changes in the activity or histology of components of the immune system to identify hazards from exposure to environmental stressors. The immune system is a complex array of components that work both independently and in concert with other components to protect humans against infection and suppress the spread of neoplasia. Given this complexity, the Agency is soliciting input from the SAB on the direction and scope of the draft guidance document. *Microbial Risk Assessment Guidance Document:* EPA is working with other government agencies to develop guidance for microbial risk assessment. The draft document is intended to reflect the issues and approaches of all contributing agencies, from which EPA will derive its own internal guidance, specific to the regulatory mandates of the program offices. The EPA has requested a consultation with the SAB EHHC on the content and direction of a draft microbial risk assessment guidance document to determine if its approach is appropriate and the content adequate. *Availability of Materials:* The draft agenda and other materials will be posted on the SAB Web site at: *http://www.epa.gov/sab* prior to the teleconference. *Procedures for Providing Public Input:* Interested members of the public may submit relevant written or oral information for the SAB to consider during the public teleconference and/or meeting on the topics included in this advisory activity and/or the group conducting the activity. *Oral Statements:* In general, individuals or groups requesting an oral presentation at a public SAB teleconference will be limited to three minutes per speaker, with no more than a total of one-half hour for all speakers. To be placed on the public speaker list, interested parties should contact Dr. Sue Shallal, DFO, in writing (preferably via e-mail), by February 22, 2008, at the contact information noted above. *Written Statements:* Written statements should be received in the SAB Staff Office in accordance with the dates mentioned above so that the information may be made available to the SAB for their consideration prior to each teleconference. Written statements should be supplied to the DFO in the following formats in electronic copy via e-mail (acceptable file format: Adobe Acrobat PDF, WordPerfect, MS Word, MS PowerPoint, or Rich Text files in IBM-PC/Windows 98/2000/XP format). *Accessibility:* For information on access or services for individuals with disabilities, please contact Dr. Sue Shallal at

(202)343-9977 or *shallal.suhair@epa.gov* . To request accommodation of a disability, please contact Dr. Shallal preferably at least ten days prior to the teleconference, to give EPA as much time as possible to process your request. Dated: January 25, 2008. Anthony F. Maciorowski, Deputy Director, EPA Science Advisory Board Staff Office. [FR Doc. E8-1913 Filed 1-31-08; 8:45 am] BILLING CODE 6560-50-P ENVIRONMENTAL PROTECTION AGENCY [ER-FRL-6695-5] Environmental Impact Statements; Notice of Availability *Responsible Agency:* Office of Federal Activities, General Information

(202)564-7167 or *http://www.epa.gov/compliance/nepa/.* Weekly receipt of Environmental Impact Statements Filed 01/21/2008 through 01/25/2008 Pursuant to 40 CFR 1506.9 EIS No. 20080028, Draft EIS, BLM, UT, West Tavaputs Plateau Natural Gas Full Field Development Plan, Develop the Natural Gas Resource on Leased and Unleased Lands, Carbon County, UT, Comment Period Ends: 05/01/2008, Contact: Brad Higdon 435-636-3613. EIS No. 20080029, Final EIS, IBR, CA, Truckee River Operating Agreement

(TROA)Modify Operations of Five Federal Two Non-Federal Reservoirs to Facilitate Distribution of Water, Truckee River Basin, Alpine, El Dorado, Nevada, Placer, Sierra Counties, CA and Carson City, Churchill Douglas, Lyon, Pershing, Storey, and Washoe Counties, NV, Wait Period Ends: 03/04/2008, Contact: Kenneth Parr 775-882-3436. EIS No. 20080030, Final EIS, BLM, MT, Upper Missouri River Breaks National Monument Resource Management Plan, Implementation, Blaine, Chouteau, Fergus and Phillips Counties, MT, Wait Period Ends: 03/04/2008, Contact: Jerry Majerus 202-452-5112. EIS No. 20080031, Draft EIS, AFS, MN, Glacier Project, To Maintain and Promote Native Vegetation, Communities that are Diverse, Productive, Healthy, Implementation, Superior National Forest, Kawishiwi Ranger District, St. Louis and Lake Counties, MN, Comment Period Ends: 03/17/2008, Contact: Susan Duffy 218-365-2097. EIS No. 20080032, Draft EIS, AFS, CO, Durango Mountain Resort Improvement Plan, Special-Use-Permits, Implementation, San Juan National Forest, La Plata and San Juan Counties, CO, Comment Period Ends: 03/17/2008, Contact: Richard Speegle 970-375-3310. EIS No. 20080033, Final EIS, BLM, CA, Truckhaven Geothermal Leasing Area, Addresses Leasing of Geothermal Resources, El Centro Field Office, Imperial County, CA, Wait Period Ends: 03/04/2008, Contact: Sandra McGinnis 916-985-4474. EIS No. 20080034, Final EIS, FHW, NH, Spaulding Turnpike Improvements Project, Reconstruction and Widening of a 3.5-mile Section from U.S. Route 4 and NH Route 16, U.S. Coast Guard Bridge Permit, NPDES Permit and U.S. Army COE Section 404 Permit, Town of Newington, City of Dover, Strafford and Rockingham Counties, NH, Wait Period Ends: 03/04/2008, Contact: William F. O'Donnell, P.E. 603-228-3057 Ext. 101. Amended Notices EIS No. 20070453, Draft EIS, BLM, UT, Monticello Field Office Resource Management Plan, To Guide the Management of Public Land, Southern two-thirds of San Juan County and small portion on the Northern boundary within Grand County, UT, Comment Period Ends: 02/08/2008, Contact: Gary Torres 435-587-1524. Revision to FR Notice Published 11/02/2007: Extending Comment Period from 01/30/2008 to 02/08/2008. Dated: January 29, 2008. Ken Mittelholtz, Environmental Protection Specialist, Office of Federal Activities. [FR Doc. E8-1854 Filed 1-31-08; 8:45 am] BILLING CODE 6560-50-P FEDERAL RESERVE SYSTEM Change in Bank Control Notices; Acquisition of Shares of Bank or Bank Holding Companies The notificants listed below have applied under the Change in Bank Control Act (12 U.S.C. 1817(j)) and § 225.41 of the Board’s Regulation Y (12 CFR 225.41) to acquire a bank or bank holding company. The factors that are considered in acting on the notices are set forth in paragraph 7 of the Act (12 U.S.C. 1817(j)(7)). The notices are available for immediate inspection at the Federal Reserve Bank indicated. The notices also will be available for inspection at the office of the Board of Governors. Interested persons may express their views in writing to the Reserve Bank indicated for that notice or to the offices of the Board of Governors. Comments must be received not later than February 15, 2008. **A. Federal Reserve Bank of Dallas** (W. Arthur Tribble, Vice President) 2200 North Pearl Street, Dallas, Texas 75201-2272: *1. Glover Loftin* , to acquire voting shares of Capital Bancorp, Inc., and thereby indirectly acquire voting shares of Commercial Capital Bank, all of Delhi, Louisiana. Board of Governors of the Federal Reserve System, January 28, 2008. Jennifer J. Johnson, Secretary of the Board. [FR Doc. E8-1817 Filed 1-31-08; 8:45 am] BILLING CODE 6210-01-S FEDERAL RESERVE SYSTEM Formations of, Acquisitions by, and Mergers of Bank Holding Companies The companies listed in this notice have applied to the Board for approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 1841 *et seq.* ) (BHC Act), Regulation Y (12 CFR Part 225), and all other applicable statutes and regulations to become a bank holding company and/or to acquire the assets or the ownership of, control of, or the power to vote shares of a bank or bank holding company and all of the banks and nonbanking companies owned by the bank holding company, including the companies listed below. The applications listed below, as well as other related filings required by the Board, are available for immediate inspection at the Federal Reserve Bank indicated. The applications also will be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the acquisition of a nonbanking company, the review also includes whether the acquisition of the nonbanking company complies with the standards in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted, nonbanking activities will be conducted throughout the United States. Additional information on all bank holding companies may be obtained from the National Information Center website at *www.ffiec.gov/nic/* . Unless otherwise noted, comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than February 25, 2008. **A. Federal Reserve Bank of Richmond** (A. Linwood Gill, III, Vice President) 701 East Byrd Street, Richmond, Virginia 23261-4528: *1. Community Bankers Acquisition Corp., Great Falls, Virginia (to be renamed Community Bankers Trust Corporation)* , to acquire 100 percent of the voting securities of BOE Financial Services of Virginia, Inc., and thereby indirectly acquire Bank of Essex, both of Tappahannock, Virginia. **B. Federal Reserve Bank of Chicago** (Burl Thornton, Assistant Vice President) 230 South LaSalle Street, Chicago, Illinois 60690-1414: *1. NRBC Holding Corporation* , to become a bank holding company by acquiring 100 percent of the voting shares of The National Republic Bank of Chicago, both of Chicago, Illinois. Board of Governors of the Federal Reserve System, January 28, 2008. Jennifer J. Johnson, Secretary of the Board. [FR Doc. E8-1816 Filed 1-31-08; 8:45 am] BILLING CODE 6210-01-S FEDERAL RESERVE SYSTEM Formations of, Acquisitions by, and Mergers of Bank Holding Companies The companies listed in this notice have applied to the Board for approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 1841 *et seq.* ) (BHC Act), Regulation Y (12 CFR Part 225), and all other applicable statutes and regulations to become a bank holding company and/or to acquire the assets or the ownership of, control of, or the power to vote shares of a bank or bank holding company and all of the banks and nonbanking companies owned by the bank holding company, including the companies listed below. The applications listed below, as well as other related filings required by the Board, are available for immediate inspection at the Federal Reserve Bank indicated. The applications also will be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). If the proposal also involves the acquisition of a nonbanking company, the review also includes whether the acquisition of the nonbanking company complies with the standards in section 4 of the BHC Act (12 U.S.C. 1843). Unless otherwise noted, nonbanking activities will be conducted throughout the United States. Additional information on all bank holding companies may be obtained from the National Information Center website at *www.ffiec.gov/nic/* . Unless otherwise noted, comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors not later than February 19, 2008. **A. Federal Reserve Bank of Atlanta** (David Tatum, Vice President) 1000 Peachtree Street, N.E., Atlanta, Georgia 30309: *1. Franklin Bancshares, Inc.* , to become a bank holding company by acquiring 100 percent of the voting shares of Bank of Franklin, both of Meadville, Mississippi. Board of Governors of the Federal Reserve System, January 29, 2008. Robert deV. Frierson, Deputy Secretary of the Board. [FR Doc. E8-1849 Filed 1-31-08; 8:45 am] BILLING CODE 6210-01-S GENERAL SERVICES ADMINISTRATION Public Building Service; Notice of Availability; Final Master Site Plan and Final Environmental Impact Statement for the Denver Federal Center, Lakewood, CO AGENCY: Public Building Service, General Services Administration. ACTION: Notice of Availability. SUMMARY: In accordance with the National Environmental Policy Act of 1969, and the President's Council on Environmental Quality Regulations (40 CFR Parts 1500-1508), as implemented by General Services Administration

(GSA)Order PBS P 1095.4D, GSA announces its Notice of Availability

(NOA)of the Final Master Site Plan Final Environmental Impact Statement

(FEIS)for the Denver Federal Center in Lakewood, Colorado. GSA proposes to implement a Master Site Plan for the Denver Federal Center, a federal facility, that addresses opportunities for future site redevelopment. The Draft Environmental Impact Statement presented two action alternatives, the Federal Quad Alternative and the Federal Mall Alternative; and a No Action Alternative. Subsequent to public review and comment, GSA determined that the Federal Quad Alternative, with modifications, would be the preferred alternative. The Federal Quad Alternative, with modifications, is the concept identified in the Final Master Site Plan. DATES: GSA will execute a Record of Decision

(ROD)based on the FEIS no sooner than March 3, 2008, or 30 days after the date of publication of this Notice of Availability in the **Federal Register** and after publication of the related notice by the Environmental Protection Agency. ADDRESSES: To obtain copies of the Master Site Plan and FEIS, contact Lisa Dorsey Wild (formerly Morpurgo), Senior Project Manager, at the U.S. General Services Administration, Rocky Mountain Region, Denver Federal Center Service Center (8PD), P.O. Box 25546, Building 41, Denver Federal Center, Denver, CO, 80225-0546. Or visit the Web site at *http://www.gsa.gov/dfcsiteplan* and follow the instructions. FOR FURTHER INFORMATION CONTACT: Ms. Lisa Dorsey Wild at

(303)236.8000 ext. 5039, by fax at 303-236-5328, e-mail at *dfcsiteplan@gsa.gov* , or mail at the above-listed address. SUPPLEMENTARY INFORMATION: The Denver Federal Center is a 640-acre secured federal facility operated by GSA. The Federal Center was acquired in 1941 by the U.S. government and is currently used for office, research, and administrative purposes by 26 federal agencies. There are approximately 4 million square feet of space in approximately 50 active buildings at the Federal Center, and there are approximately 6,000 on-site employees. The site, formerly part of unincorporated Jefferson County, Colorado, was recently annexed into the City of Lakewood. Annexation has no affect on the federal ownership or management of the site. GSA recently sold 65 of the facility the City of Lakewood through the federal land disposal process for construction of an inter-modal transit station and relocation of St. Anthony Hospital. GSA proposes to implement a new Master Site Plan for the Federal Center that will address new opportunities for site development. The FEIS, prepared to comply with the National Environmental Policy Act (NEPA), evaluates the proposed Master Site Plan alternatives and identifies the environmental effects associated with implementing the proposed alternatives. The Draft Master Site Plan and draft Environmental Impact Statement released in April 2007, evaluated two action alternatives, the Federal Quad Alternative and the Federal Mall Alternative; and a No Action Alternative. Under the No Action Alternative, GSA would not implement a new Master Site Plan for the Federal Center. Though currently planned upgrades to site infrastructure would move forward contingent upon funding, existing resources would not be leveraged to attract capital to the site, a new vision for growth would not be established, and the value and appeal of the Federal Center site would not be maximized. Under the No Action alternative, it would become increasingly difficult to maintain the resources on the site to serve Federal tenants and overall community needs. During the public review and comment period conducted between May and June 2007, over 300 hundred individual comments were received from 198 tenants, neighbors, groups, city, state, and federal offices. The Federal Quad concept, with modifications, is identified in the Final Master Site Plan and as the preferred alternative named in the FEIS. The defining characteristic of the Federal Quad Alternative is the central “Quad” that would be located in the center of the Federal Center site. The enhanced streetscapes throughout the campus would encourage area employees and residents to walk to and from transit and into adjacent districts. The Quad would be the heart of the plan and would be woven into the fabric of the surrounding neighborhoods and commercial districts via road and land use connections. The Quad would be surrounded by complementary office buildings, including secure federal buildings, non-secure federal buildings, and research buildings. A total of 227 acres (or approximately 36 percent of the total site) would be designated for open space use. The Federal Quad Alternative includes a development plan with approximately 3.6 million gross square feet of new development, plus 1,400 residential units, organized around a formal open space/park area that suggests a university campus setting. The primary change in this alternative between the Draft Master Site Plan and the Final is additional residential units in the northwest area of the site in the vicinity of the anticipated transit-orientated development and intermodal station. The modified Federal Quad Alternative as presented in the Final Master Site Plan for the Federal Center reflects GSA's preferred development strategy. Dated: January 24, 2008. Steven M. Burke, Acting Director, General Services Administration, DFC Service Center, PBS, Rocky Mountain Region. [FR Doc. E8-1908 Filed 1-31-08; 8:45 am] BILLING CODE 6820-BK-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [Document Identifier: CMS-R-50] Agency Information Collection Activities: Proposed Collection; Comment Request AGENCY: Centers for Medicare & Medicaid Services, HHS. In compliance with the requirement of section 3506(c)(2)(A) of the Paperwork Reduction Act of 1995, the Centers for Medicare & Medicaid Services

(CMS)is publishing the following summary of proposed collections for public comment. Interested persons are invited to send comments regarding this burden estimate or any other aspect of this collection of information, including any of the following subjects:

(1)The necessity and utility of the proposed information collection for the proper performance of the agency's functions;

(2)the accuracy of the estimated burden;

(3)ways to enhance the quality, utility, and clarity of the information to be collected; and

(4)the use of automated collection techniques or other forms of information technology to minimize the information collection burden. 1. *Type of Information Collection Request:* Extension of a currently approved collection; *Title of Information Collection:* Medical Records Review under the Prospective Payment System

(PPS)and Supporting Regulations in 42 CFR 412.40-412.52 *Use:* The Social Security Amendments of 1983 (Pub. L. 98-21), requires quality improvement organization

(QIO)review of medical services provided to Medicare beneficiaries. Review of services under the QIO program can be accomplished by individual case review and the Clinical Data Abstraction Centers (CDACs). Accordingly, QIOs must review, at the direction of CMS:

(1)All anti-dumping referrals;

(2)beneficiary complaints involving quality issues;

(3)potential gross and flagrant violations of unnecessary admission concerns identified during project data collection;

(4)requests from hospitals for higher-weighted DRG adjustments;

(5)hospital and managed care plan issued notices of non-coverage;

(6)specific codes for assistants at cataract surgery; and

(7)cases referred by CMS, the Office of the Inspector General, the Department of Justice, the managed care appeals contractor, intermediaries, carriers, or the CDACs. *Form Number:* CMS-R-50 (OMB# 0938-0359); *Frequency:* Yearly; *Affected Public:* Private sector—Business or other for-profit and Not-for-profit institutions; *Number of Respondents:* 6,100; *Total Annual Responses:* 276,500; *Total Annual Hours:* 8,280. To obtain copies of the supporting statement and any related forms for the proposed paperwork collections referenced above, access CMS' Web site address at *http://www.cms.hhs.gov/PaperworkReductionActof1995,* or e-mail your request, including your address, phone number, OMB number, and CMS document identifier, to *Paperwork@cms.hhs.gov,* or call the Reports Clearance Office on

(410)786-1326. In commenting on the proposed information collections, please reference the document identifier or OMB control number. To be assured consideration, comments and recommendations must be submitted in one of the following ways by April 1, 2008: 1. *Electronically.* You may submit your comments electronically to *http://www.regulations.gov.* Follow the instructions for “Comment or Submission” or “More Search Options” to find the information collection document(s) accepting comments. 2. *By regular mail.* You may mail written comments to the following address: CMS, Office of Strategic Operations and Regulatory Affairs, Division of Regulations Development, *Attention:* Document Identifier/OMB Control Number ___, Room C4-26-05, 7500 Security Boulevard, Baltimore, Maryland 21244-1850. Dated: January 25, 2008. Michelle Shortt, Director, Regulations Development Group, Office of Strategic Operations and Regulatory Affairs. [FR Doc. E8-1810 Filed 1-31-08; 8:45 am] BILLING CODE 4120-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families President's Committee for People With Intellectual Disabilities; Notice of Quarterly Meeting AGENCY: President's Committee for People with Intellectual Disabilities (PCPID); Administration for Children and Families; Department of Health and Human Services. ACTION: Notice of Quarterly Meeting. DATES: February 15, 2008, from 3:30 p.m. to 5:30 p.m. EST. The meeting will be conducted via conference call and will be open to the public using the dial-in information provided below. ADDRESSES: The conference call may be accessed on the date and time indicated by dialing 888-677-5720, passcode: 1397797. *Agenda:* PCPID will meet to finalize the 2007 Report to the President and to hear a briefing on the final report of the Ticket to Work and Work Incentives Advisory Panel. FOR FURTHER INFORMATION CONTACT: Sally D. Atwater, Executive Director, President's Committee for People with Intellectual Disabilities, The Aerospace Center, Second Floor, West, 370 L'Enfant Promenade, SW., Washington, DC 20447. Telephone: 202-619-0634, Fax: 202-205-9591. E-mail: *satwater@acf.hhs.gov.* SUPPLEMENTARY INFORMATION: PCPID acts in an advisory capacity to the President and the Secretary of Health and Human Services on a broad range of topics relating to programs, services and supports for persons with intellectual disabilities. PCPID, by Executive Order, is responsible for evaluating the adequacy of current practices in programs, services and supports for persons with intellectual disabilities, and for reviewing legislative proposals that impact the quality of life experienced by citizens with intellectual disabilities and their families. Dated: January 25, 2008. Sally D. Atwater, Executive Director, President's Committee for People with Intellectual Disabilities. [FR Doc. E8-1809 Filed 1-31-08; 8:45 am] BILLING CODE 4184-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Request for Notification from Industry Organizations Interested in Participating in the Selection Process for a Nonvoting Industry Representative on the Blood Products Advisory Committee and Request for Nominations for a Nonvoting Industry Representative on the Blood Products Advisory Committee AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration

(FDA)is requesting that any industry organizations interested in participating in the selection of a nonvoting industry representative to serve on the Blood Products Advisory Committee, Center for Biologics Evaluation and Research (CBER), notify FDA in writing. A nominee may either be self-nominated or nominated by an organization to serve as a nonvoting industry representative. Nominations will be accepted for an upcoming vacancy on September 30, 2008, effective with this notice. DATES: Any industry organization interested in participating in the selection of an appropriate nonvoting member to represent industry interests must send a letter stating the interest to FDA by March 3, 2008, for vacancies listed in the notice. Concurrently, nomination material for prospective candidates should be sent to FDA by March 3, 2008. ADDRESSES: All letters of interest and nominations should be submitted in writing to Donald W. Jehn (see FOR FURTHER INFORMATION CONTACT ). FOR FURTHER INFORMATION CONTACT: Donald W. Jehn, Division of Scientific Advisors and Consultants, Center for Biologics Evaluation and Research, Food and Drug Administration (HFM-71), 1401 Rockville Pike, Rockville, MD 20892, 301-827-1277, *donald.jehn@fda.hhs.gov* . SUPPLEMENTARY INFORMATION: The agency requests nominations for a nonvoting industry representative to the Blood Products Advisory Committee. I. Function The Blood Products Advisory Committee reviews and evaluates available data concerning the safety, effectiveness, and appropriate use of blood products derived from blood and serum or biotechnology which are intended for the use in the diagnosis, prevention, or treatment of human diseases, and, as required, any other product for which FDA has regulatory responsibility. The committee also advises the Commissioner of Food and Drugs (the Commissioner) on its findings regarding the safety, effectiveness, and labeling of the products, clinical and laboratory studies involving such products, the affirmation or revocation of biological product licenses, and on the quality and relevance of FDA's research program which provides the scientific support for regulating these agents. II. Selection Procedure Any blood products industry, association, or organization interested in the selection of an appropriate nonvoting member to represent industry interests should send a letter stating that interest to the FDA contact (see FOR FURTHER INFORMATION CONTACT ) within 30 days of publication of this document (see DATES ). Within the subsequent 30 days, FDA will send a letter to each organization that has expressed an interest, attaching a complete list of all such organizations and a list of all nominees along with their current resumes. The letter will also state that it is the responsibility of the interested organizations to confer with one another and to select a primary and alternate candidate, within 60 days after the receipt of the FDA letter, and the primary candidate will serve as the nonvoting member to represent industry interests for the Blood Products Advisory Committee. The interested organizations are not bound by the list of nominees in selecting a candidate. However, if no individual is selected within 60 days, the Commissioner will select the nonvoting member to represent industry interests. III. Application Procedure Individuals may self nominate and/or an organization may nominate one or more individuals to serve as a nonvoting industry representative. A current curriculum vitae and the name of the committee of interest should be sent to the FDA contact person (see FOR FURTHER INFORMATION CONTACT ) within 30 days (see DATES ). FDA will forward all nominations to the organizations expressing interest in participating in the selection process for the committee (persons who nominate themselves as nonvoting industry representatives will not participate in the selection process). FDA has a special interest in ensuring that women, minority groups, individuals with physical disabilities, and small businesses are adequately represented on its advisory committees, and therefore, encourages nominations for appropriately qualified candidates from these groups. This notice is issued under the Federal Advisory Committee Act (5 U.S.C. app. 2) and 21 CFR part 14, relating to advisory committees. Dated: January 24, 2008. Randall W. Lutter, Deputy Commissioner for Policy. [FR Doc. E8-1815 Filed 1-31-08; 8:45 am] BILLING CODE 4160-01-S DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration Vaccines and Related Biological Products Advisory Committee; Notice of Meeting AGENCY: Food and Drug Administration, HHS. ACTION: Notice. This notice announces a forthcoming meeting of a public advisory committee of the Food and Drug Administration (FDA). The meeting will be open to the public. *Name of Committee* : Vaccines and Related Biological Products Advisory Committee. *General Function of the Committee* : To provide advice and recommendations to the agency on FDA's regulatory issues. *Date and Time* : The meeting will be held on February 20, 2008, from 8:30 a.m. to approximately 4 p.m., and on February 21, 2008 from 8:30 a.m. to approximately 4:30 p.m. *Location* : Hilton Hotel DC North/Gaithersburg, 620 Perry Pkwy., Gaithersburg, MD 20877. *Contact Person* : Christine Walsh or Denise Royster, Center for Biologics Evaluation and Research (HFM-71), Food and Drug Administration, 1401 Rockville Pike, Rockville, MD 20852, 301-827-0314, or FDA Advisory Committee Information Line, 1-800-741-8138 (301-443-0572 in the Washington, DC area), code 3014512391. Please call the Information Line for up-to-date information on this meeting. A notice in the **Federal Register** about last minute modifications that impact a previously announced advisory committee meeting cannot always be published quickly enough to provide timely notice. Therefore, you should always check the agency's Web site and call the appropriate advisory committee hot line/phone line to learn about possible modifications before coming to the meeting. *Agenda* : On February 20, 2008, the committee will discuss and make recommendations on a rotavirus vaccine manufactured by GlaxoSmithKline Biologicals. On February 21, 2008, in the morning, the committee will discuss the selection of strains to be included in the influenza vaccine for the 2008—2009 influenza season. In the afternoon, the committee will discuss clinical development of influenza vaccines for pandemic and pre-pandemic uses. FDA intends to make background material available to the public no later than 2 business days before the meeting. If FDA is unable to post the background material on its Web site prior to the meeting, the background material will be made publicly available at the location of the advisory committee meeting, and the background material will be posted on FDA's Web site after the meeting. Background material is available at *http://www.fda.gov/ohrms/dockets/ac/acmenu.htm* , click on the year 2008 and scroll down to the appropriate advisory committee link. *Procedure* : Interested persons may present data, information, or views, orally or in writing, on issues pending before the committee. Written submissions may be made to the contact person on or before February 13, 2008. Oral presentations from the public will be scheduled between approximately 1 p.m. and 1:30 p.m. on February 20, 2008, and approximately 11:20 a.m. and 11:50 a.m. and 2:45 p.m. and 3:15 p.m. on February 21, 2008. Those desiring to make formal oral presentations should notify the contact person and submit a brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time requested to make their presentation on or before February 6, 2008. Time allotted for each presentation may be limited. If the number of registrants requesting to speak is greater than can be reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested persons regarding their request to speak by February 7, 2008. Persons attending FDA's advisory committee meetings are advised that the agency is not responsible for providing access to electrical outlets. FDA welcomes the attendance of the public at its advisory committee meetings and will make every effort to accommodate persons with physical disabilities or special needs. If you require special accommodations due to a disability, please contact Christine Walsh or Denise Royster at least 7 days in advance of the meeting. FDA is committed to the orderly conduct of its advisory committee meetings. Please visit our Web site at *http://www.fda.gov/oc/advisory/default.htm* for procedures on public conduct during advisory committee meetings. Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. app. 2). Dated: January 24, 2008. Randall W. Lutter, Deputy Commissioner for Policy. [FR Doc. E8-1889 Filed 1-31-08; 8:45 am] BILLING CODE 4160-01-S DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, February 22, 2008, 8 a.m. to February 22, 2008, 5 p.m., Holiday Inn Georgetown, 2101 Wisconsin Avenue, NW., Washington, DC 20007, which was published in the **Federal Register** on January 22, 2008, 73 FR 3733-3735. The meeting will be held February 21, 2008, 6 p.m. to February 22, 2008, 7 p.m. The meeting location remains the same. The meeting is closed to the public. Dated: January 25, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 08-435 Filed 1-31-08; 8:45 am]

Connectionstraces to 6

Traces to 6 documents

U.S. Code

CFR